Emergent BioSolutions Inc. (NYSE:EBS) Q1 2018 Earnings Conference Call May 3, 2018 5:00 PM ET
Executives
Bob Burrows - VP, IR
Dan Abdun Nabi - CEO
Bob Kramer - President and COO
Richard Lindahl - EVP, CFO and Treasurer
Adam R. Havey - EVP, Business Operations
Analysts
Christopher Staral - Goldman Sachs
Keay Nakae - Chardan Capital Markets
Jessica Fye - JPMorgan
David Maris - Wells Fargo
François Brisebois - Laidlaw
Lisa Springer - Singular Research
Operator
Good day, ladies and gentlemen, and welcome to the Emergent BioSolutions 1Q 2018 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference is being recorded.
I would now like to turn the call over to the company, Emergent BioSolutions. You may begin.
